INTRODUCTION
Klebsiella pneumoniae is an important nosocomial pathogen that causes suppurative lesions, septicaemia, and urinary and respiratory tract infections in immunocompromised patients (Han, 1995; Schelenz et al., 2007) . A steady increase in the incidence of Klebsiella liver abscesses (KLAs) in patients with diabetes, malignancy, renal disease or pneumonia has been observed in Taiwan (Fung et al., 2002) . Reports of KLAs have also increased in Western and other Asian countries (Pope et al., 2011) . Although KLA pathogenic mechanisms remain obscure, several virulence traits, including the vast amount of K1 capsular polysaccharide surrounding the bacteria surface (Fung et al., 2002) , magA (Chuang et al., 2006) , iron acquisition loci on pLVPK (Tang et al., 2010) and type 1 fimbriae (Struve et al., 2008 (Struve et al., , 2009 Stahlhut et al., 2012) , have been reported. Fimbriae (also called pili) allow bacteria to attach to host cells to establish infection. Type 1 fimbriae expressed by most members of the family Enterobacteriaceae are commonly associated with urinary tract infections and bind to the mannose-containing structure present on host cells or in the extracellular matrix (Ishikawa, 1991; Jones et al., 1995) . The expression of type 1 fimbriae is phase-variable and is mediated by an invertible 314 bp cis element, fimS, located upstream of the type 1 fimbrial major subunit gene, fimA. The fimS switching, which alternates Escherichia coli between type 1 fimbriated and non-fimbriated states, is controlled by site-specific recombinases FimB and FimE. In addition, DNA-binding proteins IHF and Lrp can specifically bend fimS DNA, enabling proper positioning of the inverted repeat sequences to facilitate recombination (Schwan, 2011) . single fimAICDFGH operon (Rosen et al., 2008) . The FimK protein of a K. pneumoniae urinary tract infection isolate negatively affects the expression of type 1 fimbriae. This may be caused by the involvement of cyclic di-GMP (c-di-GMP) phosphodiesterase (PDE) activity (Rosen et al., 2008) . This possibility is supported by the multiple sequence alignment data of Fig. S1 , available in Microbiology online, which reveals a conserved EAL domain at the C terminus of FimK. In addition to the EAL domain, a DNA-binding domain has been predicted in FimK (Struve et al., 2008) . Amino acid sequence analysis on the basis of Pfam classification also showed a putative helix-turn-helix DNA-binding motif from the HTH_23 family (http://pfam.sanger.ac.uk/) at the N-terminal region of FimK.
Analysis of the genome sequence of K. pneumoniae CG43 (unpublished data), a liver abscess isolate that belongs to the K2 serotype (Chang et al., 1996) , showed that the type 1 fimbriae gene cluster is physically linked and divergently transcribed to the type 3 fimbriae operon. This study reports FimK-mediated regulation of type 1 fimbriae expression at the transcriptional level in K. pneumoniae CG43S3, which may be achieved by binding with the HTH domain of FimK to the fimS DNA. The changed protein 
METHODS
Bacterial strains, plasmid, primer and growth conditions. Table  1 lists the bacterial strains and plasmids used in this study, and Table  2 lists the primers. Bacteria were grown in Luria-Bertani (LB) broth with shaking at 37 uC, unless otherwise indicated. Antibiotics used included ampicillin (100 mg ml 21 ), kanamycin (25 mg ml 21 ), streptomycin (500 mg ml 21 ), chloramphenicol (35 mg ml
21
) and tetracycline (12.5 mg ml
).
Immunoelectron microscopy. K. pneumoniae CG43S3 was grown overnight in LB broth with shaking, and 20 ml of the bacterial suspension (10 8 c.f.u. ml
) was added to collodion-coated 300-mesh copper grids. The bacteria coated on the grids were then incubated with a 1 : 50 dilution of the previously prepared anti-MrkA polyclonal antibody (Huang et al., 2009) , followed by incubation with a 1 : 65 dilution of 10 nm gold particles conjugated with protein A (Sigma-Aldrich P9660). After negatively staining with 2 % (w/v) phosphotungstic acid, pH 7.2, the grids were examined under a JEOL JEM 2000EXII transmission electron microscope at an operating voltage of 100 kV.
FimA antisera preparation. The fimA coding sequence was amplified by PCR from K. pneumoniae CG43S3 and ligated into expression vector pET30a. Recombinant plasmid pET30a-fimA was then transformed into E. coli NovaBlueBL21(DE3), and overexpression of the recombinant protein His 6 -FimA was induced with 0.5 mM IPTG for 5 h at 37 uC. The insoluble fraction was denatured using 6 M urea and then the protein purified using a nickel column (Novagen) saturated with 6 M urea. Finally, 3 mg of the purified His 6 -FimA was used to immunize rabbits for the anti-FimA antibody.
Constructing the gene deletion mutants. Specific gene deletion was introduced into the chromosome of K. pneumoniae CG43S3 using an allelic-exchange strategy (Lai et al., 2003) . Briefly, DNA fragments of 1 kb flanking both ends of mrkA, fimK, EIL fimK and HTH fimK DNA were amplified by PCR with primer sets SL0141/ SL0142 and SL0143/SL0158, K1/K2 and K3/K4, WCC32/WCC33 and WCC34/WCC35, and WCC127/CC128 and WC133/WCC130, respectively. The amplified DNA fragments were individually cloned into suicide vector pKAS46 (Skorupski & Taylor, 1996) . The resulting plasmid was transformed into E. coli S17-1lpir and then mobilized by conjugating to the streptomycin-resistant strain, K. pneumoniae CG43S3 (Lai et al., 2003) . Several kanamycin-resistant transconjugants, with the plasmid integrated into the chromosome by homologous recombination, were selected from the M9 agar plates supplemented with kanamycin and propagated in 2 ml LB broth overnight. A small aliquot of the culture was plated on LB agar containing 500 mg streptomycin ml
. Colonies susceptible to kanamycin were isolated, and the specific gene deletions were verified by PCR analysis.
Quantitative reverse-transcription PCR (qRT-PCR). Total RNA was isolated from bacteria using a High Pure RNA isolation kit (Roche), and residual DNA was eliminated with RNase-free DNase I according to the manufacturer's instructions. The cDNAs used for PCR were synthesized from 1.5 mg RNA using a random hexamer primer form RevertAid H Minus First-strand cDNA synthesis kit (Fermentas). PCR was performed using an ABI Prism 7000 Detection system according to manufacturer's instructions, and products were detected using SYBR Green PCR Master Mix (Roche). The RNA samples were normalized to the 23S rRNA level. Analysis was performed in triplicate in a reaction volume of 25 ml containing 12.5 ml SYBR Green PCR Master Mix, 300 nM primer pair, 9.5 ml distilled H 2 O and 1 ml cDNA. Samples were heated for 10 min at 95 uC and amplified for 40 cycles of 15 s at 95 uC and 60 s at 60 uC. Quantification was performed using the 2 -DDCT method (Tsai et al., 2009) .
Western blot analysis of FimA and MrkA expression. Aliquots of total cellular lysates were resolved by SDS-PAGE, and proteins were electrophoretically transferred onto a PVDF membrane (Millipore). After incubation with 5 % skimmed milk at room temperature for 1 h, the membrane was washed three times in PBS with Tween 20 (PBST). The membrane was then incubated with anti-GAPDH (GeneTex), anti-FimA or anti-MrkA antiserum at room temperature for 2 h. After three washes with 16 PBST, the PVDF membrane was incubated with a 1 : 5000 dilution of the secondary antibody, alkaline phosphatase-conjugated anti-rabbit immunoglobulin G, at room temperature for 1 h. Finally, the blot was rewashed, and the secondary antibodies bound on the PVDF membrane were detected using chromogenic reagents 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium.
Yeast-cell agglutination. Agglutination of yeast Saccharomyces cerevisiae AH109 was conducted as described by Blumer et al. (2005) . Bacteria (10 9 c.f.u. ml 21 ) were suspended in PBS with or without mannose and then mixed with yeast (10 mg ml 21 ) on a glass slide. The degree of clumping was assessed by observation.
Biofilm formation assay. As described previously (Lin et al., 2006; Wu et al., 2010) , bacteria diluted 1 : 100 in LB broth supplemented with appropriate antibiotics were inoculated into each well of a 96-well microtitre dish (Orange Scientific) and statically incubated at 37 uC for 20 h. After removing planktonic cells, the wells were washed once with distilled water to remove unattached cells. Crystal violet (0.1 % w/v; Sigma-Aldrich) was used to stain the attached cells for 30 min. Unattached dye was removed by washing three times with distilled water. The stained biomass was dissolved in 1 % (w/v) SDS, and the OD 595 was determined to assess biofilm-forming activity.
Plasmid construction. The coding region of fimB, fimK, the Nterminal regions of the HTH domain (1-218 aa) or EIL domain (195-469 aa) of fimK, and mrkJ were PCR-amplified with primer pairs B1/B2, WCC71/WCC74, WCC71/WCC72, WCC73/WCC74 and WCC77/WCC78, respectively, from the CG43S3 genome. The amplified DNA was individually cloned into cloning vector yT&A (Yeastern Biotech). Site-directed mutation plasmid pyT-fimK E245A was generated by substituting the glutamic acid at FimK position 245 with alanine using plasmid pyT-fimK as a template with overlapping primers M1 or M2 by PCR-based mutagenesis. Primer pair WCC73/ WCC74 was then used to amplify the AIL fimK coding region using pyT-fimK E245A as a template.
For complementation analysis or protein overexpression, the coding region from pyT-fimB, pyT-fimK, pyT-fimK E245A , pyT-HTH fimK , pyT-EIL fimK , pyT-AIL fimK or pyT-mrkJ was subcloned into the broad-hostrange vector pRK415 (Keen et al., 1988) or expression vectors pETQ31, pETQ33 (Wu et al., 2010) , pQE31 (Qiagen) or pET30a (Novagen). This resulted in low-copy-number complementation plasmids pRK415-fimK, pRK415-fimK E245A , pRK415-HTH fimK and pRK415-EIL fimK and overexpression clones pETQ33-fimB, pETQ31-EIL fimK , pETQ31-AIL fimK , pQE31-fimK, pETQ33-EIL fimK , pETQ33-AIL fimK , pETQ33-mrkJ and pET30a-mrkJ. The coding region of gene ydeH (Jonas et al., 2008) was PCR-amplified with primer pair WCC75/WCC76 from the E. coli MG1655 genome and cloned into yT&A to generate plasmid pyT-ydeH. The ydeH coding DNA was then isolated from pyT-ydeH by restriction enzyme digestion and then cloned into pETQ33 to yield YdeH expression plasmid pETQ33-ydeH.
Promoter activity measurement. The putative promoter regions of fimA, fimB and fimE were PCR-amplified with primers pfimA3/ pfimA4, pfimB4/pfimB5 and pfimE1/pfimE2, respectively. The amplicons were then cloned into placZ15 (Lin et al., 2006) to generate P fimA -lacZ (locked on), P fimB -lacZ and P fimE -lacZ. The promoter-reporter plasmids were individually mobilized into K. pneumoniae CG43S3 strains by conjugation from E. coli S17-1lpir. The bacteria were grown to the exponential phase in LB broth (OD 600 of 0.7), and 100 ml of the culture was mixed with 900 ml of Z buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , 50 mM b-mercaptoethanol), 17 ml of 0.1 % SDS and 35 ml chloroform, followed by vigorous shaking. After incubation at 30 uC for 5 min, 200 ml of a 4 mg ml 21 concentration of ONPG (SigmaAldrich) was added to the mixture to initiate the reaction. When the mixture became yellow, the reaction was stopped by adding 500 ml 1 M Na 2 CO 3 and the absorbance at OD 420 was recorded. The promoter activity was expressed as Miller units. Each sample was assayed in triplicate and at least three independent experiments were conducted. The data were calculated from one representative experiment and are shown as the means and SD from three samples.
Expression and purification of the recombinant proteins.
Recombinant plasmids pETQ31-EIL fimK and pETQ31-AIL fimK were transformed into E. coli JM109, and protein production was induced with 0.5 mM IPTG for 12 h at 22 uC. The expression plasmid pET30a-mrkJ was introduced into E. coli NovaBlue BL21(DE3), and recombinant His 6 -MrkJ was induced with 0.5 mM IPTG for 5 h at 37 uC. The recombinant protein His 6 -FimK was induced in E. coli SG13009 [pREP4] with 0.01 mM IPTG for 24 h at 15 uC. All recombinant proteins were then purified from the soluble fraction of the cell lysate by affinity chromatography using His-Bind resin according to the QIAexpress expression system protocol (Qiagen). The purified proteins were dialysed against Tris-buffered saline (pH 7.4) containing 10 % (v/v) glycerol at 4 uC overnight, followed by condensation with PEG 20 000. Protein purity was determined by SDS-PAGE.
DNA electrophoretic mobility shift assay (EMSA). The variant truncated putative promoter of fimA was PCR-amplified using biotinlabelled primer pairs WCC93/WCC96, WCC93/WCC99, WCC93/ WCC98, WCC95/WCC91, WCC95/WCC90, WCC95/WCC89 and WCC121/WCC123 or non-labelled primer pairs WCC94/WCC96 and WCC122/WCC123. The DNA-binding reaction was performed in 20 ml binding buffer [100 nM MnCl 2 , 1 mM MgCl 2 , 0.5 mM DTT, . The bacteria carrying pETQ33 or pETQ33-fimB plasmid were grown at 37 6C for 2 h, and subsequently grown in the presence of 0.5 mM IPTG for 4 h. The bacteria carrying pRK415 or the derivative plasmids were grown in LB broth supplemented with 0.01 mM IPTG for 20 h at 37 6C. On: Wed, 15 May 2019 21:18:01 50 mM KCl, 10 mM Tris/HCl (pH 7.5), 0.05 mg BSA ml 21 and 4 % (v/v) glycerol]. In the reaction, sheared salmon sperm DNA was added at 0.05 mg ml 21 to prevent non-specific DNA binding. After transferring to a Biodyne B nylon membrane, biotin-labelled DNA was detected using a LightShift chemiluminescent EMSA kit (Pierce).
PDE activity measurement. An in vitro PDE activity assay was performed as described by Johnson & Clegg (2010) with 300 nM of the purified recombinant proteins or a non-phosphodiesterase control, BSA (Sigma-Aldrich), in assay buffer [50 mM Tris/HCl, 1 mM MnCl 2 (pH 8.5)] supplemented with 5 mM bis(p-nitrophenol) phosphate (bis-pNPP). Reaction mixtures were incubated at 37 uC for 3 h, and the release of p-nitrophenol was quantified at 405 nm.
Swimming activity analysis. The coding regions of EIL fimK , AIL fimK , mrkJ and ydeH were amplified from pyT-fimK, pyT-fimK E245A , pyTmrkJ and pyT-ydeH, respectively, with primer pairs WCC83/WCC84, WCC85/WCC86 and WCC79/WCC80 ( Table 2 ). The amplified DNA products were individually cloned into expression vector pBAD33 (Guzman et al., 1995) , and the resulting plasmids were transformed into E. coli JM109. Swimming activity analysis for the recombinant bacteria was then conducted as described by Wood et al. (2006) . Four microlitres of the bacteria grown overnight carrying pBAD33-EIL fimK , pBAD33-AIL fimK , pBAD33-mrkJ or pBAD33-ydeH was spotted onto a tryptone swimming plate (0.25 % Bacto agar, 0.25 % NaCl, 1 % tryptone, 35 mg chloramphenicol ml 21 and 0.1 % arabinose), and the plate was incubated for 12 h at 37 uC.
Measuring c-di-GMP level in K. pneumoniae CG43S3.
Expression plasmids pETQ33, pETQ33-EIL FimK , pETQ33-AIL FimK or pETQ33-ydeH were individually transformed into K. pneumoniae CG43S3, and overexpression of the recombinant proteins was induced with 0.5 mM IPTG for 4 h at 37 uC. To measure the c-di-GMP content, cellular extracts were prepared as described by Simm et al. (2004) . The IPTG-induced bacteria were collected and treated with formaldehyde (0.19 % final concentration), and then pelleted by centrifugation. The pellet was suspended in de-ionized water and heated to 95 uC for 10 min before nucleotides were extracted using 65 % ethanol. The lyophilized samples were resuspended in deionized water, and the suspension was used to detect c-di-GMP with the cyclic diguanylate ELISA kit (Wuhan EIAab Science).
RESULTS
Inverse expression of type 1 and 3 fimbriae in K. pneumoniae CG43S3 Transmission electron microscopy detection with an immunogold-labelled antibody against the major pilin, MrkA, was used to demonstrate the synthesis of type 3 fimbriae on the surface of K. pneumonaie CG43S3 (Fig. 1a) . Expression of the fim operon could be assessed by the restriction pattern of the fimS DNA amplified from the bacterial culture. Fig. 1(b) shows some incomplete digested amplicons and the BsaBI restriction fragments of approximately 450 and 200 bp, corresponding to the phase 'OFF' fimS in CG43S3. This restriction pattern reflects no detectable expression of the type 1 fimbriae. The expression of type 1 fimbriae pilin FimA was only evident in the mrkA deletion mutant, as shown by qRT-PCR and Western blot analysis (Fig. 1c) . The results show that deleting the predominant type 3 fimbriae pilin mrkA gene increased type 1 fimbriae expression. The inverse expression pattern between the two types of fimbriae was further observed by introducing pETQ33-fimB, which overexpresses the FimB recombinase, into K. pneumoniae CG43S3. Fig. 2(a) shows that overexpression of the FimB recombinase turns on expression of FimA but depletes MrkA production.
FimK plays a positive regulatory role in the expression of type 1 fimbriae As shown in Fig. 2(a) , deleting fimK from CG43S3[pETQ33-fimB] slightly decreased the expression of FimA but greatly increased the expression of MrkA as judged by immunoblot analysis targeting MrkA and FimA. However, deleting only the DNA coding for the in an in-frame fashion from CG43S3[pETQ33-fimB] had no apparent effect on FimA production. To further confirm the regulatory role of FimK on the expression of type 1 fimbriae, the FimK-coding DNA and the DNA coding for the HTH domain were individually deleted in an in-frame fashion from CG43S3DmrkA. Compared with CG43S3DmrkA, CG43S3DmrkADfimK and CG43S3DmrkADHTH fimK reduced FimA production slightly while CG43S3DmrkADEIL fimK had no apparent effect on FimA expression (Fig. 2b) . The results suggest that the FimK regulation of type 1 fimbriae is dependent on the N-terminal DNA-binding domain. As shown in Fig. 2(c) , introducing plasmid pRK415-fimK or pRK415-HTH fimK , which expressed an intact FimK or the FimK DNA-binding domain, into CG43S3DmrkADfimK increased FimA expression levels. The FimK-dependent type 1 fimbriae activities were also observed using mannosesensitive yeast agglutination assay. As shown in Fig. S2(a, b) , deleting fimK from CG43S3[pETQ33-fimB] or CG43S3-DmrkA had no dramatic change on the mannose-sensitive agglutination activity. However, the complementation analysis clearly revealed an FimK-or HTH domain-dependent mannosesensitive agglutination activity (Fig. S2c) . These results suggest that FimK positively affects the type 1 fimbriae expression possibly through its N-terminal DNA-binding domain.
respectively, the inverted repeat right and left of fimS and the transcription start site. Lower panel: the promoter activity of fimA, fimB and fimE as, respectively, assessed by expression of the b-galactosidase reporter plasmid P fimA -lacZ (locked on), P fimBlacZ and P fimE -lacZ, in K. pneumoniae CG43S3DlacZDmrkA and its isogenic derivatives DlacZDmrkADfimK and DlacZDmrkADEIL fimK were determined. (c) Two-plasmid heterologous expression analysis in E. coli JM109 for the regulation of FimK on the fimA promoter activity. Expression of fimA assessed via b-galactosidase activity of the strains JM109[P fimAlacZ][pRK415-fimK] and JM109[PlacZ15][pRK415-fimK], and also the control strain JM109[P fimA -lacZ] with or without IPTG addition into the cultures. The bacteria were grown in LB broth at 37 6C and FimK expression was induced with 0.5 mM IPTG for 5 h. Data represent an average of three independent experiments.
FimK regulation of K. pneumoniae type 1 fimbriae
The N-terminal domain of FimK positively influences P fimA activity To investigate whether the fimK gene affects type 1 fimbriae biosynthesis at a transcriptional level, the fimA transcript level was determined using qPCR. As shown in Fig. 3(a) , introducing either plasmid pRK415-fimK or pRK415-fimK E245A into CG43S3DmrkA increased the fimA transcripts to approximately twice the value of CG43S3DmrkA[pRK415] or CG43S3DmrkA[pRK415-EIL fimK ]. This suggests that the fimA transcript-level change might not be directly influenced (c) The biotin-labelled DNA probes P2*, P3*, P4*, P5*, P6* and P7* were applied for the specific binding region.
by the C-terminal EIL domain. To investigate whether the Nterminal DNA-binding domain of FimK enhanced type 1 fimbriae expression by regulating fimB or fimE promoter activity or directly affected fimA promoter activity, a LacZ reporter assay was performed. Fig. 1(b) shows that the fimS is mostly OFF-phased in CG43S3, and a locked ON fimA promoter was therefore used. These promoter activities in CG43S3DfimK appeared to be at similar levels to those in CG43S3 (data not shown). We reason that fimK is transcribed as part of the fimAICDFGH operon (Rosen et al., 2008) and expression of type 1 fimbriae in CG43S3 is not detected in the culture condition. Therefore, the promoter activities of fimA, fimB and fimE were measured in CG43S3DmrkA to examine the fimK gene deletion effect.
As shown in Fig. 3(b) , the promoter activity of fimA, but not of fimB or fimE, was reduced by deleting fimK. This suggests that FimK affects type 1 fimbriae expression by directly influencing the fimA promoter. The negative effect was not observed for P fimA in CG43S3DmrkADEIL fimk , implying that the N-terminal region of FimK plays a regulatory role. As shown in Fig. 3 (c), P fimA activity in E. coli JM109 was not changed with IPTG addition, while heterologous expression of FimK by IPTG induction increased the expression levels of fimA, further supporting a direct regulation of FimK on fimA.
Recombinant FimK exhibits a specific DNAbinding activity with P fimA
The DNA fragments encompassing the full-length fimS (P1) and the truncated forms P2*, P3*, P4*, P5*, P6* and P7* as depicted in Fig. 4 (a) were isolated and biotin-labelled for the analysis. As shown in Fig. 4(b) , formation of the P1*/FimK complex could be observed as the amount of His 6 -FimK increased, and the binding specificity was demonstrated as the complex diminished in the presence of excess nonlabelled P1 or P7 acting as specific competitor DNA. The sheared salmon sperm DNA was added as non-specific competitor reagent. Fig. 4(c) shows that the purified recombinant His 6 -FimK protein was able to bind to the DNA probes P2, P3, P6 and P7, but not to P4 or P5. The results support the conclusion that the recombinant FimK protein could specifically interact with fimS DNA and also suggest that the FimK-binding site is located within P7.
The recombinant FimK protein exerts PDE activity
Some PDE domain proteins do not exhibit PDE-specific enzyme activity (Römling, 2009), so we studied whether FimK possesses PDE activity. As shown in Fig. 5(a) , the purified recombinant FimK exhibited considerably less bis-PNPP catalytic activity than the recombinant MrkJ, for which PDE activity has been reported (Johnson et al., 2011) . Recombinant clones expressing EIL fimK and AIL fimK containing the C-terminal EIL domain of FimK and the domain with critical E245 residue replaced with alanine, respectively, were also generated and the corresponding overexpressed proteins were purified. The recombinant EIL fimK exhibited a higher level of PDE activity than the recombinant FimK and AIL fimK . The FimK protein exhibited the lowest PDE activity of all the tested proteins, except the negative control BSA.
The second-messenger c-di-GMP levels determine whether E. coli and many other bacteria are in a motile or sessile state (Jonas et al., 2009) . As assessed using swimming activity analysis shown in Fig. 5(b FimK regulation of K. pneumoniae type 1 fimbriae which expresses diguanylate cyclase activity (Jonas et al., 2008) . The result supports that the FimK EIL domain exerts PDE activity, which is able to lower the intracellular c-di-GMP content, thereby increasing motility of the recombinant E. coli.
FimA production is not directly dependent on c-di-GMP levels
To further confirm EIL fimK PDE activity, the c-di-GMP levels in K. pneumoniae CG43S3 transformed with pETQ33, pETQ33-ydeH, pETQ33-EIL fimK and pETQ33-AIL fimK were measured. As shown in Fig. 6(a) , also confirming c-di-GMP PDE activity of EIL fimK .
Comparative analysis of the bacteria which carry different c-di-GMP levels was conducted to determine if the secondmessenger levels regulate the expression of type 1 fimbriae. As shown in Fig. 6(b , indicating that FimA production is not directly affected by c-di-GMP level. Despite this, the c-di-GMP level change altered MrkA production and biofilm formation (Fig. 6c) .
DISCUSSION
Research shows that cross-talk regulation may occur between different fimbriae (Snyder et al., 2005; Sjöström et al., 2009) . In E. coli, during coordinate regulation for type 1 and type P fimbriae, PapB, a regulator for type P fimbriae expression, inhibits FimB-promoted recombination, thereby affecting the expression of type 1 fimbriae (Xia et al., 2000) . Analysing K. pneumoniae CG43 genome sequences revealed at least ten fimbriae-coding gene clusters (unpublished data). It is possible that the expression of individual adhesins must be cooperatively regulated in the bacteria. Fimbriated and non-fimbriated planktonic cells display different outer-membrane protein patterns (Otto et al., 2001) . Decreased expression of type 1 fimbriae was reported for the E. coli K1 ompA deletion mutant (Teng et al., 2006) . Misfolding of the P fimbriae subunit triggered the 2CS Cpx and s E regulatory pathways (Jones et al., 1997) . These studies suggest that deleting mrkA may change the outer-membrane protein pattern or trigger an envelope stress system, leading to the expression of type 1 fimbriae in K. pneumoniae CG43S3.
As shown in Fig. 2(b) , deleting fimK from the mrkA deletion mutant reduced FimA production. These reduction effects were not observed in CG43S3DmrkADEIL fimK , suggesting that FimK regulates fim expression through the N-terminal region. Complementation analysis confirms that the HTH fimK domain, but not the C-terminal EIL domain, positively regulates type 1 fimbriae expression via increasing fimA transcription (Figs 2c and 3a) . Our LacZ reporter assay and EMSA data indicated that FimK may bind to an fimS region upstream of the fimA transcriptional start site and then activate fimA promoter activity. In E. coli, IHF and Lrp could specifically bind on and bent fimS DNA, enabling proper positioning of the inverted repeat sequences to facilitate recombination (Schwan, 2011) . EMSA data indicate that FimK binds to P7* DNA. Regional sequence analysis identified a putative IHF binding sequence, 59-TNYAANNNR-TTGAT-39, where Y is pyrimidine and R is purine (Eisenstein et al., 1987) . In Salmonella enterica serovar Typhimurium, the fimA promoter is activated when FimZ forms a complex with FimY protein but repressed by the FimZ-FimW complex (McFarland et al., 2008) . Hence, FimK may regulate fim expression by cooperating with IHF or Lrp or an unidentified protein such as FimZ in S. Typhimurium. Nevertheless, FimK-mediated regulation may be also achieved by changing the structure of onphase DNA, thereby improving transcription, or by facilitating fimS switch from off to on through altering the interaction between DNA and FimB or FimE recombinase.
As shown in Fig. S1 , the FimK EIL domain includes the critical residues involved in Mg 2+ substrate binding and Loop 6 required for signal transduction (Rao et al., 2008 (Rao et al., , 2009 Römling, 2009 ). This suggests PDE activity for FimK. Several studies have shown that PDE activity was inactivated when critical residue E from the EAL domain was replaced with alanine (Kuchma et al., 2007; Bassis & Visick, 2010) . However, recombinant proteins EIL fimK and AIL fimK expressed PDE activity, and only AIL fimK exhibited lower enzyme activity levels. When responding to different internal and external signals, the sensory modules, such as PAS, GAF, HAMP, REC and HTH domains, commonly present with the GGDEF, EAL and HD-GYP domains, activate diguanylate cyclase or PDE activity (Ho et al., 2000; Galperin et al., 2001; Christen et al., 2005; Tamayo et al., 2007; Cruz et al., 2012) . FimK exerted higher PDE activity when the N-terminal DNA-binding domain was removed, suggesting that PDE activity may be activated after the N-terminal domain is stimulated by a specific signal.
This study provides novel insight into the function and mechanism of FimK regulating type 1 fimbriation in K.
pneumoniae. The data demonstrate that FimK positively affects the expression of type 1 fimbriae at the transcriptional level by modulating P fimA promoter activity after binding to fimS. When interaction between the N-terminal domain and DNA occurs, FimK PDE activity may be activated to reduce intracellular c-di-GMP levels, thus negatively affecting the expression of other surface structures, such as type 3 fimbriae (Wilksch et al., 2011) . . Bacteria carrying pETQ33 and other derivative plasmids were grown to mid-exponential phase and then supplemented with 0.5 mM IPTG, and the culture continued for 4 h at 37 6C. Thereafter, total proteins were isolated and resolved by SDS-PAGE. The proteins were transferred to PVDF membrane and hybridized with anti-FimA, anti-MrkA or anti-GAPDH. (c) Biofilm formation activity. Bacteria were inoculated into each well of a 96-well microtitre dish and statically incubated at 37 6C for 20 h, and then the biofilm-forming activity measurement was performed as described in Methods.
